Gout Screening Identifies a Large Cardiovascular Population at Increased Risk of Mortality.
Silvia Ruiz-SimónIrene CalabuigMiguel Gómez-GarberíMariano AndrèsPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022)
Gout was an independent predictor of subsequent all-cause mortality in patients admitted for cardiovascular events. Active screening for gout allowed the detection of a larger population at high risk of mortality and could help tailor patient management to minimize the cardiovascular impact.